Tag Archives: MHC class I

Peptide-loaded exosomes are promising cancer treatment vehicles; however, moderate T cell responses in human clinical trials indicate a need to further understand exosome-induced immunity. Researchers from the Karolinska Institute previously demonstrated that antigen-loaded exosomes carry whole protein antigens and require ...

Read More »